Test ID: CGAK
Chromogranin A, Serum
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Follow-up or surveillance of patients with known or treated carcinoid tumors
Adjunct in the diagnosis of carcinoid tumors
Adjunct in the diagnosis of other neuroendocrine tumors, including pheochromocytomas, medullary thyroid carcinomas, functioning and nonfunctioning islet cell and gastrointestinal amine precursor uptake and decarboxylation tumors, and pituitary adenomas
A possible adjunct in outcome prediction and follow-up in advanced prostate cancer
Method Name A short description of the method used to perform the test
Homogeneous Time-Resolved Fluorescence
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Chromogranin A, S
External
link
PDF
document
Excel
document
Word
document